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Background: Systematic nodal dissection (SND) is regarded as a core component of lung cancer surgery. However,
there has been a concern on the increased morbidity associated with SND. This study was performed to investigate
whether or not SND induces significant immune response.
Methods: Sixteen dogs were divided into two groups; group 1 (n = 8) underwent thoracotomy only, and group 2
(n = 8) underwent SND after thoracotomy. We compared interleukin-6 (IL-6) levels in serum, pleural lavage fluid and
lung supernatant at the time of thoracotomy (T0) and at 2 h(T1) after thoracotomy (group 1) or SND (group 2).
Severity of inflammation and IL-6 expression in lung tissue were evaluated in a semi-quantitative manner.
Results: The operative results were comparable. IL-6 was not detected in serum in either group. IL-6 in pleural
lavage fluid marginally increased from 4.75 ± 3.74 pg/mL at T0 to 19.75 ± 8.67 pg/mL at T1 in group 1 (P = 0.112),
and from 7.75 ± 5.35 pg/mL to 17.72 ± 8.58 pg/mL in group 2 (P = 0.068). IL-6 in lung supernatant increased
from 0.36 ± 0.14 pg/mL/mg to 1.15 ± 0.17 pg/mL/mg in group 1 (P = 0.003), and from 0.25 ± 0.08 pg/mL/mg to
0.82 ± 0.17 pg/mL/mg in group 2 (P = 0.001). However, the degree of increase in IL-6 in pleural lavage fluid and
lung supernatant were not different between two groups (P = 0.421 and P = 0.448). There was no difference in
severity of inflammation and IL-6 expression between groups.
Conclusions: SND did not increase IL-6 in pleural lavage fluid and lung supernatant. This result suggests that SND
could be routinely performed in lung cancer surgery without increasing the significant inflammatory response.
Keywords: IL-6, Lung cancer, Mediastinal lymph node dissectionBackground
Mediastinal and hilar lymph node dissection has been a
core component of lung cancer surgery since Cahan repor-
ted the first series of pulmonary lobectomies with regional
lymph node dissection [1]. In 1996, the International As-
sociation for the Study of Lung Cancer (IASLC) accepted
systematic nodal dissection (SND) as an integral feature of* Correspondence: kdjcool@yuhs.ac
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reproduction in any medium, provided the orintra-thoracic cancer surgery [2]. During SND, all lymph
nodes and surrounding fatty tissue within anatomic land-
marks are removed, enabling accurate surgical staging. In
addition, SND has the potential to provide survival bene-
fits over systematic lymph node sampling (SLS), in which
certain lymph nodes are removed to a lesser extent. How-
ever, concerns have been raised regarding increased mor-
bidity rates associated with SND. Okada et al. reported a
significantly higher morbidity rate for SND as compared
to SLS, which may be attributed to increased tissue dam-
age [3]. In contrast, several other studies failed to demon-
strate differences in operative morbidity between SND
and SLS [4,5]. To date, a consensus regarding the potential. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reached. One explanation might be that all studies in-
cluded a concomitant pulmonary resection followed by
SND, which prevented them from specifically attributing
any observed surgical morbidity to the application of
SND. In addition, the type of resection (sub-lobar resec-
tion, lobectomy, or pneumonectomy), the amount of
blood loss during pulmonary resection, and the total op-
erating time, are all significant contributors to postoper-
ative morbidity, which may obscure the determination
of differences caused by the type of lymphadenectomy.
The concentration of immune response mediators as
measured in body fluids is a well-established indicator of
surgical injury. Among the cytokines activated during
the acute phase response after a major surgery, interleukin-6
(IL-6) has been correlated to the severity of surgical stress
[6] as well as the subsequent morbidity and mortality
[7,8]. After an injury, the levels of IL-6 in the circulation
become detectable within 60 min, peak between 2 and
3 hours, and can persist for as long as 10 days in humans
[9]. In canine models, IL-6 levels are also significantly
increased following a local injury, and change faster than
other acute phase proteins, such as tumor necrosis factor
or C-reactive protein (CRP) [10]. The purpose of this
study was to investigate whether SND carries an added
risk of significant surgical injury. To achieve this, we eval-
uated the changes in IL-6 in serum, pleural lavage fluid,
and lung supernatant in a canine thoracotomy model
without performing a pulmonary resection.
Methods
Experimental animals
A total of 16 dogs, weighing 10.5 to 20.1 kg, with similar
genetic backgrounds were used in this study. The ani-
mals were housed in cages maintained at a controlled
temperature of 22 to 24°C and kept on a standard diet.
The dogs were assigned group 1 (n = 8), which under-
went thoracotomy only, or group 2 (n = 8), which
underwent thoracotomy followed by SND. The experi-
mental animal protocol was approved by the Animal
Ethics Board, College of Medicine Research Centre, King
Saud University.
Operation
Anesthesia was induced by intramuscular injection of keta-
mine (4 mg/kg)/xylazine (0.4 mg/kg), after which orotra-
cheal intubation was performed using a 7.0 to 7.5 mm
endotracheal tube. A tracheostomy was performed, allo-
wing introduction of a smaller endotracheal tube into the
left main bronchus, under bronchoscopic guidance, to
achieve the single-lung ventilation. The anesthesia was
maintained with 0.5% of sevoflurane, and mechanical
ventilation was employed with a tidal volume of 10 mL/kg
and a respiratory rate of 25 to 30 breaths/min. Electro-cardiography and pulse oximetry were monitored through-
out the procedure.
A right lateral thoracotomy was performed after ad-
ministration of antibiotics, and the intercostal space was
spread using a self-retractor. As soon as the thoracot-
omy was completed, 5 mL of venous blood was sampled,
and 100 mL of warm normal saline was injected into the
pleural cavity before any further manipulation. The fluid
was irrigated by hand over the visceral and parietal
pleura for 1 min, and sampled. Lung tissue was har-
vested from the edge of the anterior segment of the right
upper lobe using an endostapler. The blood and pleural
lavage samples were forwarded to the immunology la-
boratory, and the lung tissue was sent fresh in a sealed
plastic container.
For the animals in group 1, no further procedure was
added, and the sampling was redone 2 hours following
the start of the thoracotomy; this time frame was cho-
senbecause the levels of IL-6 in the circulation become
detectable within 60 min, and peak between 2 and
3 hours after surgical injury [9]. In group 2, SND of pul-
monary hilum and mediastinum was performed follow-
ing the initial thoracotomy. With the right lung under
retraction, en bloc resection of all the lymph nodes and
surrounding fatty tissue within the anatomic landmarks
(superior vena cava, trachea, bronchus, and pericardium)
was carried out. After 2 hours, blood, pleural fluid lav-
age, and lung tissue were sampled in a manner consist-
ent with group 1. Thus, we compared the levels of IL-6
in serum, pleural lavage and lung supernatant at the
time of thoracotomy (T0) and at 2 hours (T1) after ei-
ther thoracotomy (group 1) or SND (group 2). The total
operation time, SND time, and the amount of blood loss
were recorded. After T1, the thoracotomy was closed,
and the animals were monitored for 2 weeks.
Blood and pleural lavage fluid were cooled to 4°C, cen-
trifuged at 2,500 rpm for 10 min, transferred into sterile
1.0 mL tubes and preserved at −80°C for later analysis.
Each lung tissue sample was bisected and each half was
weighed. One half of the lung tissue was forwarded to
the immunology laboratory for ELISA and the other was
submitted for histopathological evaluation.
Hematoxylinand eosin (H&E) staining and
immunohistochemistry (IHC)
Lung tissue was fixed in 10% formalin, then processed
in a Tissue-Tek® VIP®6 vacuum infiltration processor
(Sakura Finetek, Tokyo, Japan). The tissue samples were
embedded in paraffin, cut in 5-μm thick sections using a
microtome, and either stained with H&E or mouse
monoclonal IL-6 antibody (BD Bioscience, San Jose,
USA) for IHC. Two histopathologists examined the
slides in a double-blinded manner, and independently
reported their findings.
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of inflammatory cells (lymphocytes, histiocytes, macro-
phages and neutrophils). An assessment of inflammatory
infiltration was made for specific areas of the lung tissue
(subpleural, peribronchial and random location). Because
there is no standardized grading system for the severity
of inflammation and the degree of IL-6 staining in this
model, we devised the grading system as follows; nega-
tive: less than 5 inflammatory cells per 3 high power
fields (HPFs); mild: 5 to 10 inflammatory cells per 3
HPFs; moderate: 10 to 15 inflammatory cells per 3
HPFs; and severe: >15 inflammatory cells per 3 HPFs.
The purpose of IHC staining was to identify the IL-6
expressing inflammatory cells. To evaluate the amount
of IL-6 positive cells, a semi-quantitative scoring system
was applied as follows. For the amount of positive cells:
no cells stained: 0; less than 5 inflammatory cells show
IL-6 staining: 1; 5 to 25%: 2; 26 to 50%: 3; 51 to 75%: 4;
76 to 100%: 5. For the signal intensity; 1: weak staining,
2: moderate staining, 3: strong staining. The maximum
combined score of proportion and intensity was 8. Non-
specific IL-6 positive cells such as intra-alveolar macro-
phages and bronchial epithelial cells were identified and
disregarded.
ELISA assay
A section of the lung tissue sample was weighed and
immediately incubated with RPMI-1640 culture medium
supplemented with 10% fetal calf serum in an atmos-
phere of 95% air and 5% CO2 at 37°C. After 12 hours,
the supernatant was collected. The IL-6 levels were mea-
sured using the ELISA technique according to the man-
ufacturer’s instructions (Diasource, Nivelles, Belgium)
and expressed as pg IL-6 per mL of supernatant (pg/mL)
derived from 1 mg lung tissue. In addition, plasma and
pleural lavage fluid were subjected to ELISA using the
same antibody, and those values were expressed as pg
IL-6 per mL plasma or pleural lavage fluid, respectively.
Statistical analysis
The results were expressed as mean ± standard error of
the mean. The differences between the two groups wereTable 1 Operative data
Group
Body weight (kg) 13.70 ± 1
Induction time for anaesthesia (minutes) 28.50 ± 1
Total operating time (minutes) 151.25 ±
Systematic node dissection time (minutes) N/A*
Weight of lymph nodes (mg) N/A*
Number of lymph nodes N/A*
Estimated blood loss (mL) 6.88 ± 0
*N/A; not applicable.analyzed using independent t-test. Changes within the
groups were analyzed using a paired t-test. All data were
recorded in a database and analyzed with SPSS 20.0 soft-
ware (SPSS Inc., Chicago, IL, USA). A result was consid-
ered statistically significant when the Pvalue was less than
0.05. All statistical analysis were reviewed and verified by
a statistician.
Results
Operative results
The operative results are described in Table 1. Between
the two groups the body weight, anesthesia induction
time, and estimated blood loss were comparable. As
SND was added to the procedure in group 2, taking
11.75 ± 0.90 min, the total operating time was longer in
group 2 than in group 1 (151.25 ± 2.70 vs. 162.13 ± 2.46,
P= 0.027). During SND, an average of 3.44 ± 0.37 lymph
nodes were dissected, weighting 2.88 ± 0.91 mg. There
was no incidence of mortality in either group.
H&E staining
For H&E staining, samples were derived from all but one
animal, and 5 to 10 inflammatory cells were observed
per 3 HPFs; most inflammatory infiltrates were composed
of lymphocytes, histiocytes, or interstitial macrophages.
There was no difference in the degree of inflammation
between the two groups, and the amount of inflammatory
infiltrates was not increased by the SND procedure.
IHC
At T0, inflammatory cells from both groups were found to
express IL-6. The expression scores were similar (3 (range:
0–4) for group 1, vs.2.5 (range: 0–4) for group 2, P = 0.3).
The IL-6 scores at T1 (3 (range: 2–4) for group 1 and 3
(range: 2–5) for group 2) did not differ significantly (P= 0.3).
No differences in immunohistochemical staining patterns
were observed after SND in group 2 (Figure 1).
IL-6 levels in pleural lavage fluid
The difference in IL-6 levels at T0 (4.75 ± 3.74 pg/mL in
group 1, and 7.75 ± 5.35 pg/mL in group 2) did not
reach statistical significance (P = 0.721). At T1, the IL-61 Group 2 P
.02 15.18 ± 0.94 0.304
.42 35.08 ± 3.37 0.082
2.70 162.13 ± 3.46 0.027
11.75 ± 0.90 N/A*
3.44 ± 0.37 N/A*
2.88 ± 0.91 N/A*
.91 32.50 ± 14.82 0.106
Figure 1 IL-6 expression in lung tissue. The photomicrograph shows sections from a dog lung treated with IL-6 IHC stains before (A, ×200)
and after SND (B, ×400). There are aggregates of mononuclear inflammatory cells with moderately intense staining of cytoplasm and cell
membrane. There was no difference in IL-6 expression score between the groups.
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group 1, P = 0.112 and 17.72 ± 8.58 pg/mL in group 2,
P= 0.075), but there was no significant difference be-
tween the groups (P= 0.432, Figure 2A).
IL-6 levels in lung supernatant and serum
In both groups the IL-6 levels increased significantly
over time (group 1: 0.36 ± 0.14 pg/mL/mg at T0, 1.15 ±
0.17 pg/mL/mg at T1, P= 0.003, vs. group 2: 0.25 ±
0.08 pg/mL/mg at T0, 0.8 ± 0.17 pg/mL/mg at T1, P= 0.001).
There were no significant differences between the two
groups (P= 0.448, Figure 2B). IL-6 was not detectable in
the serum in either group, even after SND was performed.
Discussion
SND is an essential component of lung cancer surgery.
It facilitates accurate staging and guidance for adjuvant
therapy after resection. In 1996, SND was accepted by
the IASLC as a core component of intrathoracic lung
cancer staging [2]. SND is regarded as mandatory in some
regions, where it is believed to increase the probability ofFigure 2 IL-6 levels in pleural lavage fluid (A) and lung supernatant (B
thoracotomy, but there was no difference between group 1 and group 2 (
after thoracotomy, but there was no difference between group 1 and groucurative therapy, hence improving the survival rate. How-
ever, a recent survey revealed that approximately 40% of
surgical lung cancer patients did not undergo any lymph
node dissection at the time of surgery [11].
There are several explanations for the low rate of
SND, the main reasons being longer operation time and
concerns about the potentially associated morbidity. Sev-
eral clinical studies showed contradictory results; Okada
et al. reported a higher incidence of pneumonia, atelec-
tasis, and chylothorax after SND when compared with
SLS [3], whereas other studies reported similar outcomes
between the two modalities [4,5,12]. However, these re-
ports are observational clinical studies, in which all pa-
tients underwent a pulmonary resection before or
following the SND. Compared to major surgery, the ef-
fects of SND are likely negligible. For example, a patient
undergoing a pneumonectomy without lymph node dis-
section might endure more surgical stress than a patient
undergoing a pulmonary lobectomy with SND. In
addition, the amount of bleeding, the effectiveness of
single-lung ventilation, the fluid balance, and the total). (A) In both groups, IL-6 was marginally increased 2 hours after
P= 0.432). (B) IL-6 was significantly increased in both groups 2 hours
p 2 (P= 0.448).
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morbidity. These factors complicate the comparison of
pulmonary surgery patients with regards to the contribu-
tion of SND to postoperative morbidity. We therefore
opted for an experimental study, in which we could
evaluate the surgical injuries as caused by SND while ex-
cluding any overshadowing effects caused by a concomitant
pulmonary resection.
We used IL-6 as a marker for the extent and severity
of surgical injury. Among cytokines activated during the
acute phase response, IL-6 is significantly correlated
with postoperative mortality and morbidity rates [7,8].
Recent studies have revealed that IL-6 is produced locally
at the surgical site, and a variety of cells such as alveolar
macrophages, lung fibroblasts, and airway epithelial cells
can produce IL-6 under certain conditions [13,14]. In our
canine model, IL-6 was significantly increased following
local injury, which is consistent with reports detailing the
IL-6 response in humans [10].
Our study showed that SND does not independently
elicit a significant surgical injury. The IL-6 level was
increased in pleural lavage fluid and lung supernatant in
both groups regardless of the performance ofSND. Con-
sidering that IL-6 was increased at T1 in group 1, this in-
crease seems to have been caused by factors independent
of SND. For instance, single-lung ventilation might pro-
mote the production and release of IL-6 in the alveoli. A
high inspiratory pressure in the contralateral lung might
cause barotrauma and subsequent deterioration of the
alveolar-capillary barrier [15]. In addition, single-lung
ventilation-induced atelectasis and re-expansion might in-
duce ischemia-reperfusion injury, which leads to the pro-
duction of inflammatory cytokines [16]. Also, mechanical
stress on the right lung, such as retraction, compression,
or massaging of lung tissue, may also cause production of
IL-6. Finally, the thoracotomy itself may induce surgical
stress. It is well known that a lobectomy via thoracotomy
causes a higher cytokine response than a lobectomy via
video-assisted thoracic surgery [17]. Given that the degree
of change in IL-6 levels in both groups was not significant,
we conclude that SND had little effect on the production
and release of IL-6. Therefore, our findings support the
position that SND is a safe and feasible procedure which
does not increase the surgical stress.
While IL-6 was not detected in serum in either group, it
was increased in pleural lavage fluid and lung supernatant.
On IHC staining of lung tissue, IL-6 was mainly expressed
on lymphocytes, histiocytes, and interstitial macrophages.
These findings suggest that in the very early postoperative
period, these cells may play an important role in the pro-
duction of IL-6. Recent studies reported that bronchial
epithelial cells were responsible for IL-6 production
in vivo and in vitro [18,19]. Lung tissue may be a potential
source of cytokine production during thoracic surgery.This study has some limitations. First, because we
intended to analyze the ‘acute’ response following sur-
gery, we measured the IL-6 levels only for 2 hours after
the procedure. In order to document the effect of SND
on postoperative morbidity, serial follow-up of IL-6 and
monitoring of complications such as pneumonic infiltra-
tion on X-ray until the seventh postoperative day are
needed. Given that the IL-6 level peaks within 2 hours
of surgery [20], our method seems adequate to compare
the degree of acute surgical injury between two groups.
Second, we measured only IL-6 as an inflammatory
marker because IL-6 has been correlated to the severity
of surgical stress and subsequent mortality and morbid-
ity [6-8]. Measuring other acute phase proteins such as
tumor necrosis factor and CRP could offer more infor-
mation on the inflammatory changes. However, we
thought that IL-6 is the best indicator for this study be-
cause it is significantly increased after a local injury and
is elevated faster than other acute phase proteins [10].
Third, we did not measure anti-inflammatory cytokines.
The regulation of inflammation by anti-inflammatory
cytokines is complicated as a number of related external
factors should be considered; further, there have been no
studies on the relationship between these cytokines and
surgical injury in a canine model. Because IL-6 has been
reported as an indicator of inflammatory status in both
human and animals, we tested IL-6 levels only. Finally,
even though the mean number of dissected lymph nodes
after complete mediastinal lymph node dissection in
group 2 was about 2.8, the paucity of dissected lymph
nodes could be criticized as a limitation. However, dur-
ing thoracic operations of dogs and pigs for training pur-
poses, we observed few lymph nodes in either of these
animals. Even though dissected lymph nodes in this
study were small, we completely dissected lymph nodes
and fat tissue at each station. In spite of these limitations,
to our knowledge, this is the first study investigating
whether SND carries an added risk of significant surgical
injury in an animal model.
Conclusions
In summary, SND did not independently contribute to
an increase in the level of IL-6 in serum, pleural lavage
fluid, and lung supernatant in a canine model of thora-
cotomy. These results support the routine application of
SND during lung cancer surgery because it offers accurate
staging and increased likelihood of curative therapy in
selected patients without increasing the significant inflam-
matory response.
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